Merck profit tops estimates as Keytruda sales surge
Reuters: Health News
(Reuters) - Merck & Co Inc's quarterly profit blew past analysts' estimates on Friday as sales of its key immuno-oncology drug Keytruda nearly tripled.
LONDON (Reuters) - Britain's two big drugmakers face very different challenges but they share a common problem: how to convince investors that their dividends are safe.
NYT > Health
Most Americans are eating far more protein than they actually need.
Here are some key lessons from the vote early Friday that seemingly brought an end to Republicans’ seven-year dream of dismantling Obamacare.
No comments:
Post a Comment